Acino International AG announces new Chairman of the Board
Zurich, March 26, 2019 – Acino International AG announced today the appointment of John Beighton as Chairman of the Board. He will join the Board as of March 26, 2019 and succeed Håkan Björklund, who has decided to step down.
Mr. Björklund joined the Acino Board as Chairman in December 2013 upon the company’s acquisition by Nordic Capital and Avista Capital, and its subsequent delisting from the Swiss stock market.
“On behalf of the board, I would like to thank Håkan for his many years of service, as well as his strategic insight and invaluable business experience”, said Olof Faxander, Vice-Chairman and Head of Operations with Nordic Capital.
John Beighton has been serving as interim Chief Executive Officer and Advisory Board Member for Zentiva. He has over 37 years’ experience in the healthcare industry and started his career with Smithkline Beecham. He is the former Chief Executive Officer of Mercury Pharma and managed the successful merger with Amdipharm to create AMCo. More recently he ensured a smooth transition of AMCo when it was acquired by Concordia. He holds a BSc in Biochemistry from the University of Manchester and is a British citizen.
“John’s extensive knowledge in generics and experience in working in private equity will be valuable assets to Acino, and we look forward to working with him to secure Acino’s future growth”, added Tom Dean, Board Member and Co-CEO of Avista Capital.
For all external enquiries please contact:
Sara Vermeulen-Anastasi
Head of Corporate Communications
sara.vermeulen@acino.swiss
No other employee is authorized to make statements on behalf of Acino unless otherwise stated by official contacts